Aktivatory plazminogena urokinaznogo i tkanevogo tipov i ikh ingibitor pervogo tipa pri rake pishchevoda (predvaritel'nye rezul'taty)

by E S Gershteyn, D Yu Goncharov, N E Kushlinekiy, I V Poddubnaya
Published 2001-12-01

Klinicheskoe znachenie sistemy aktivatsii plazminogena u bol'nykh rakom zheludka

by A I Kaz'min, N A Ognerubov, E S Gershteyn, N E Kushlinskiy
Published 2004-06-01

Issledovanie vozmozhnykh mekhanizmov regulyatsii rosta razlichnykh novoobrazovaniy u detey

by K O Dumbrays, N E Kushlinskiy, E S Gershteyn, T G Glazkova, V N Baykova, L A Durnov
Published 2001-03-01

CLINICAL SIGNIFICANCE OF THE VEGFR-2 IN THE TUMORS AND BLOOD SERA OF THE BREAST CANCER PATIENTS

by E. A. Kim, A. M. Platova, I. V. Visotzkaya, E. S. Gershteyn, V. P. Letyagin, N. E. Kushlinskiy, E. E. Mironova
Published 2014-09-01

DEVELOPMENT OF A MULTIPLEX ALLELE-SPECIFIC REAL-TIME PCR METHOD FOR DETECTION OF PIK3CA GENE SOMATIC MUTATIONS AND ITS VALIDATION IN THE TUMORS OF BREAST CANCER PATIENTS

by M. L. Filipenko, D. V. Shamovskaya, N. A. Oskina, I. P. Oscorbin, E. A. Khrapov, L. K. Ovchinnikova, E. S. Gershteyn, N. E. Kushlinskii
Published 2016-02-01

CLINICAL IMPLICATIONS OF INSULIN-LIKE GROWTH FACTORS (IGF) AND IGF-BINDING PROTEINS INVESTIGATION IN PATIENTS WITH OVARIAN NEOPLASMS

by E. S. Gershteyn, D. N. Kushlinskiy, E. A. Korotkova, E. R. Isaeva, V. D. Ermilova, K. P. Laktionov, L. V. Adamyan, N. E. Kushlinskii
Published 2016-02-01